In the group of fatty liver, females were older significantly (52.02 ± 12.98 vs. 50.56 ± 12.70, p-value=0.005), had lower SBP, DBP, drug duration, FBS, 2hpp, HbA1C, TG, Cr, uric acid, AST, ALT and higher Chol, HDL, LDL, BMI and ALKP, although there were no statistically significant in the prevalence of microvascular complications in fatty liver group based on gender (Table 1). This evidence concerns the gene GPT and Hepatic steatosis.